Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.56 EUR | -0.64% | 0.00% | -5.45% |
06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
Sales 2024 * | 750K 700K 62.5M | Sales 2025 * | 750K 700K 62.5M | Capitalization | 135M 126M 11.23B |
---|---|---|---|---|---|
Net income 2024 * | -143M -134M -11.92B | Net income 2025 * | -146M -136M -12.17B | EV / Sales 2024 * | 180 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 180 x |
P/E ratio 2024 * |
-1.16
x | P/E ratio 2025 * |
-1.54
x | Employees | 220 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.84% |
Latest transcript on I-Mab
1 day | -0.64% | ||
Current month | -1.89% | ||
1 month | -1.27% | ||
3 months | -8.77% | ||
6 months | -5.45% | ||
Current year | -5.45% |
Managers | Title | Age | Since |
---|---|---|---|
Rajkumar Kannan
CEO | Chief Executive Officer | 61 | 22/23/22 |
Jerry Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yi Fei Zhu
PRN | Corporate Officer/Principal | 55 | 10/20/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chia Hung Yang
BRD | Director/Board Member | 61 | 01/20/01 |
Pamela Klein
CHM | Chairman | 63 | 01/20/01 |
Shuai Chen
BRD | Director/Board Member | 50 | 01/23/01 |
Date | Price | Change |
---|---|---|
28/24/28 | 1.56 | -0.64% |
27/24/27 | 1.57 | -1.26% |
26/24/26 | 1.59 | +0.63% |
25/24/25 | 1.58 | +1.94% |
24/24/24 | 1.55 | -0.64% |
Delayed Quote Deutsche Boerse AG, June 28, 2024 at 11:33 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock